Feinstein Institutes' Journals Hit Record Impact Factors
Event summary
- Molecular Medicine journal's impact factor rose to 8.3 from 6.4, its highest since 1994.
- Bioelectronic Medicine received its first-ever impact factor of 6.8.
- Molecular Medicine now ranks 38th in Biochemistry & Molecular Biology and 40th in Cell Biology categories.
- Bioelectronic Medicine ranks 23rd in Engineering, Biomedical and 42nd in Neurosciences categories.
The big picture
The Feinstein Institutes' journals are gaining traction in competitive scientific publishing, reflecting broader industry trends toward interdisciplinary research. The rise of Bioelectronic Medicine aligns with growing interest in neuromodulation as a treatment alternative to pharmaceuticals, particularly after the FDA's landmark approval in 2025.
What we're watching
- Research Influence
- How the rising impact factors will affect submission rates and citation metrics for both journals.
- Field Growth
- Whether Bioelectronic Medicine can sustain its momentum following the FDA's 2025 approval of a vagus nerve implant stimulator.
- Cross-Disciplinary Impact
- The pace at which bioelectronic medicine integrates advancements in AI, material science, and immunology into clinical applications.
Related topics